In Multiple Sclerosis, the immune system attacks the protective sheath (myelin) around nerves in the brain, eye and spinal cord.
As with damaged electrical wires, signals sent along damaged nerves between brain and body can be slowed or blocked.
At least 2.3 million people worldwide have MS – more than the population of Orlando.
The average person in the U.S. has about a 1 in 750 (0.13%) chance of developing MS.
Most people with MS have a relapsing-remitting course, which often develops into secondary-progressive. Others never experience periods of relapse; this is called primary-progressive.
Periods of new symptoms, followed by periods of remission—the most common course.
Increasing Disability over Time
Periods of new symptoms, followed by steady progression of symptoms.
Gradual onset and steady progression without remission.
Steroids or plasma exchange are used to treat new symptoms. Most patients improve.
14 injectable, oral and infusion therapies are approved to prevent new symptoms and disability.
Patients with MS require an integrated team, tailored to their needs to manage symptoms like: weakness, walking problems, muscle stiffness, bladder problems.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.